Kim Forest Enterprise Co., Ltd. (TPE:6645)
Taiwan · Delayed Price · Currency is TWD 15.90
-0.10 (-0.63%)
Jun 25, 2026, 1:30 PM CST
Kim Forest Enterprise Market Cap
Kim Forest Enterprise has a market cap or net worth of 960.11 million as of June 25, 2026. Its market cap has decreased by -21.91% in one year.
Market Cap
960.11M
Enterprise Value
1.33B
Revenue
570.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.90
Market Cap Chart
Since August 18, 2017, Kim Forest Enterprise's market cap has increased from 545.05M to 960.11M, an increase of 76.15%. That is a compound annual growth rate of 6.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 960.11M | -10.53% |
| Dec 31, 2025 | 1.07B | -16.65% |
| Dec 31, 2024 | 1.29B | -24.16% |
| Dec 29, 2023 | 1.70B | 21.03% |
| Dec 30, 2022 | 1.40B | 32.47% |
| Dec 30, 2021 | 1.06B | -29.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIONET | 3.57B |
| DIVA Laboratories | 1.76B |
| Genetics Generation Advancement | 1.07B |
| Puriblood Medical | 1.00B |
| Sofiva Genomics | 808.67M |
| TFBS Bioscience | 697.04M |
| Welgene Biotech | 410.15M |
| Pharmigene | 375.46M |